Avalus European Registry - an Observational Study to Evaluate Safety and Efficacy in a Real World Population
NCT ID: NCT05572710
Last Updated: 2024-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2020-06-10
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective European Multicenter Study on Aortic Valve Replacement: (E-AVR Registry)
NCT03143361
Registry to Evaluate the Impact of a Valve Coordinator on Aortic Stenosis / TAVI Outcome - (German Pilot)
NCT03570190
Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement
NCT05261204
Evaluation of BAV in Different Hemodynamic Entities of Severe AS
NCT04053192
Evaluation of Endothelial Dysfunction During Aortic Valvular Replacement by Bioprosthesis With and Without Extracorporeal Circulation
NCT03135496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal of this project is to evaluate the real world results of aortic valve replacement with the Avalus valve. This will result in clinical and hemodynamic knowledge of this particular valve. The investigators are aiming for 1000 patient inclusions distributed over 40 sites across Europe and potentially also involving Canada.
Intentionally, we kept the inclusion criteria as wide as possible in order to obtain a real-world experience with and performance of the bioprosthesis. Patients younger than 18 years and salvage procedures are the only exclusion criteria from the registry. Outcome is evaluated in accordance with the VARC-2 criteria up to 1-year postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>= 18 years
* Patient has been adequately informed of risks and requirements of the registry (which are actually limited since the prosthesis is in full commercial use and only data registration is performed) and is able to provide informed consent for participation in the clinical registry.
Exclusion Criteria
* Not been able to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
UCL St Luc
Brussels, , Belgium
ZOL
Genk, , Belgium
AZ Maria Middelares
Ghent, , Belgium
UZ Gent
Ghent, , Belgium
Rigshospitalet
Copenhagen, , Denmark
Kuopio University Hospital
Kuopio, , Finland
CHU Nantes
Nantes, , France
Schüchtermann-Klinik
Bad Rothenfelde, , Germany
Universität Herzzentrum
Hamburg, , Germany
Osp. S.Orsola Malpighi
Bologna, , Italy
Fondazione Poliambulanza
Brescia, , Italy
Villa Maria Cecilia
Cotignola, , Italy
Policlinico San Donato S.P.A
Milan, , Italy
European Hospital
Roma, , Italy
A. Sanitaria O. Ordine Mauriziano
Torino, , Italy
UMC Maastricht
Maastricht, , Netherlands
Hospital Rambla
Santa Cruz de Tenerife, , Spain
Hospital Clinico De Valladolid
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Laurent de Kerckhove
Role: primary
Chris Van Kerrebroeck
Role: primary
Koen Cathenis
Role: primary
Katrien Francois
Role: primary
Jesper Ravn
Role: primary
Pekka Jaakkola
Role: primary
J. Roussel
Role: primary
Nicolas Doll
Role: primary
Hermann Reichenspurner
Role: primary
D. Pacini
Role: primary
G. Troise
Role: primary
Alberto Giovanni Tripodi
Role: primary
A. Canziani
Role: primary
R. De Paulis
Role: primary
P. Centofanti
Role: primary
Roberto Lorusso
Role: primary
Rafael Llorens
Role: primary
Juan Bustamante
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S63824
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.